In breast and lung cancer, ROS-induced TRPA1 activation leads to intracellular Ca2+ oscillations that engage antioxidant and pro-survival signaling pathways, resulting in cancer cell tolerance to oxidative stress. Here, TRPA1 is linked to lung carcinoma.